The Recall Desk

FDA (Drugs) recall action 90289

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy recalled 2 products on 2022-06-15

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2022-06-15
Critical
0
Units
—

Why these products were recalled

Subpotent drug

The agency’s own wording, quoted from the enforcement report.

States named across these recalls

1–2 of 2

  • SevereFDA (Drugs)··2022-06-15

    Tacrolimus Compounded Suspension Recalled Due to Subpotency

    Valor Compounding Pharmacy recalls compounded Tacrolimus 0.5 mg/mL suspension due to subpotency. The medication, distributed in California, may not provide adequate therapeutic levels for immunosuppression in transplant patients.

    Product
    Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,
    Category
    Distribution
    1 state
  • SevereFDA (Drugs)··2022-06-15

    FDA Recalls Compounded Tacrolimus Suspension Due to Subpotency

    Valor Compounding Pharmacy issued a Class I recall for compounded Tacrolimus suspension (Lot 04272022@35) distributed in California due to subpotency.

    Product
    Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704
    Category
    Distribution
    1 state